BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19727665)

  • 1. Efficacy of leptin therapy in the different forms of human lipodystrophy.
    Chong AY; Lupsa BC; Cochran EK; Gorden P
    Diabetologia; 2010 Jan; 53(1):27-35. PubMed ID: 19727665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
    Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
    J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
    Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P
    Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.
    Guettier JM; Park JY; Cochran EK; Poitou C; Basdevant A; Meier M; Clément K; Magré J; Gorden P
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):547-554. PubMed ID: 18076675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
    J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
    Safar Zadeh E; Lungu AO; Cochran EK; Brown RJ; Ghany MG; Heller T; Kleiner DE; Gorden P
    J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy.
    Oral EA; Javor ED; Ding L; Uzel G; Cochran EK; Young JR; DePaoli AM; Holland SM; Gorden P
    J Clin Endocrinol Metab; 2006 Feb; 91(2):621-8. PubMed ID: 16317060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-replacement therapy for lipodystrophy.
    Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
    N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
    Chan JL; Lutz K; Cochran E; Huang W; Peters Y; Weyer C; Gorden P
    Endocr Pract; 2011; 17(6):922-32. PubMed ID: 22068254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of stopping and restarting leptin in an adolescent with lipodystrophy.
    Kamran F; Rother KI; Cochran E; Safar Zadeh E; Gorden P; Brown RJ
    Horm Res Paediatr; 2012; 78(5-6):320-5. PubMed ID: 22965160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
    Mulligan K; Khatami H; Schwarz JM; Sakkas GK; DePaoli AM; Tai VW; Wen MJ; Lee GA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1137-44. PubMed ID: 19174500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.
    Brown RJ; Valencia A; Startzell M; Cochran E; Walter PJ; Garraffo HM; Cai H; Gharib AM; Ouwerkerk R; Courville AB; Bernstein S; Brychta RJ; Chen KY; Walter M; Auh S; Gorden P
    J Clin Invest; 2018 Aug; 128(8):3504-3516. PubMed ID: 29723161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
    Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.
    Oral EA; Ruiz E; Andewelt A; Sebring N; Wagner AJ; Depaoli AM; Gorden P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3110-7. PubMed ID: 12107209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
    Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    Nguyen ML; Sachdev V; Burklow TR; Li W; Startzell M; Auh S; Brown RJ
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4327-e4339. PubMed ID: 34223895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
    Diker-Cohen T; Cochran E; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.
    Javor ED; Moran SA; Young JR; Cochran EK; DePaoli AM; Oral EA; Turman MA; Blackett PR; Savage DB; O'Rahilly S; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3199-207. PubMed ID: 15240593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
    Ebihara K; Kusakabe T; Hirata M; Masuzaki H; Miyanaga F; Kobayashi N; Tanaka T; Chusho H; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; DePaoli AM; Fukushima M; Nakao K
    J Clin Endocrinol Metab; 2007 Feb; 92(2):532-41. PubMed ID: 17118991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.